Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor?

Lung Cancer

Volumn 66, Issue 2, 2009, Pages 262-267

  Hsu, Li Han ^a   Chu, Nei Min ^a   Liu, Chia Chuan ^a   Tsai, Stella Y C ^a   You, Dong Ling ^a   Ko, Jen Sheng ^a   Lu, Mei Chun ^a   Feng, An Chen ^a  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

Author keywords

Bronchiolo alveolar carcinoma; Gender; Non small cell lung cancer; Smoking; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; THORACOTOMY; TREATMENT PLANNING;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS; SMOKING;

EID: 70350341923     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.01.020     Document Type: Article

References (40)

1. Bureau of Health Promotion, Department of Health, The Executive Yuan, Taiwan. Cancer registration system, annual report 2005. Taiwan Press, 2008:52-3.
2. Patel J.D., Bach P.B., and Kris M.G. Lung cancer in US women: a contemporary epidemic. JAMA 291 (2004) 1763-1768
3. Patel J.D. Lung cancer in women. J Clin Oncol 23 (2005) 3212-3218
4. Pauk N., Kubik A., Zatloukal P., and Krepela E. Lung cancer in women. Lung Cancer 48 (2005) 1-9
5. Thomas L., Doyle L.A., and Edelman M.J. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest 128 (2005) 370-381
6. Wisnivesky J.P., and Halm E.A. Sex differences in lung cancer survival: do tumors behave differently in elderly women?. J Clin Oncol 25 (2007) 1705-1712
7. Bryant A., and Cerfolio R.J. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 132 (2007) 185-192
8. Sculier J.P., Chansky K., Crowley J.J., Meerbeeck J.V., and Goldstraw P. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol 3 (2008) 457-466
9. Wakelee H.A., Wang W., Schiller J.H., Langer C.J., Sandler A.B., Belani C.P., et al. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group Trial 1594. J Thorac Oncol 1 (2006) 441-446
10. Bureau of Health Promotion, Department of Health, The Executive Yuan, Taiwan: Smoking behavior online search system. http://tobacco.bhp.doh.gov.tw:8080/.
11. Fukuoka M., Yano S., and Giaccone G. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer. J Clin Oncol 21 (2003) 2237-2246
12. Kris M.G., NataleRB, and Herbst R.S. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 290 (2003) 2149-2158
13. Hsu L.H., Ko J.S., You D.L., Liu C.C., and Chu N.M. Trans-bronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography. Respirology 12 (2007) 848-855
14. Mountain C.F. Revisions in the international staging system for lung cancer. Chest 111 (1997) 1710-1717
15. Toh C.K., Wong E.H., Lim W.T., Leong S.S., Fong K.W., Wee J., et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective study. Chest 126 (2004) 1750-1756
16. Toh C.K., Gao F., Lim W.T., Leong S.S., Fong K.W., Yap S.P., et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 24 (2006) 2245-2251
17. Cerfolio R.J., Bryant A.S., Scott E., Sharma M., Robert F., Spencer S.A., et al. Women with pathological stage I, II, and III non-small cell lung cancer have better survival than men. Chest 130 (2006) 1796-1802
18. Batevik R., Grong K., Segadal L., and Stangeland L. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and elative survival over 15 years. Lung Cancer 47 (2005) 173-181
19. Eddy D.M. Screening for lung cancer. Ann Intern Med 111 (1989) 232-237
20. Bain C., Feskanich D., Speizer F.E., Thun M., Hertzmark E., Rosner B.A., et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96 (2004) 826-834
21. International Early Lung Cancer Action Program Investigators. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 296 (2006) 180-184
22. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 1999. CA Cancer J Clin 49 (1999) 8-31
23. Centers for Disease Control (CDC), National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Women and smoking: a report of the Surgeon General. U.S. Public Health Service, Office of the Surgeon General, 2001 at http://www.cdc.gov/tobacco/sgr/sgr_forwomen/index.htm.
24. Yano T., Miura N., Takenaka T., Haro A., Okazaki H., Ohba T., et al. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer 113 (2008) 1012-1018
25. Fujisawa T., Lizasa T., Saitoh Y., Sekine Y., Motohashi S.I., Yasukawa T., et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 17 (1999) 2086-2091
26. Nordquist L.T., Simon G.R., Cantor A., Alberts W.M., and Bepler G. Improved survival in never-smokers vs. current smokers with primary adenocarcinoma of the lung. Chest 126 (2004) 347-351
27. Sobue T., Suzuki T., Fujimoto I., Doi O., Tateishi R., and Sato T. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit. Jpn J Cancer Res 82 (1991) 33-39
28. Kawai H., Tada A., Kawahara M., Nakai K., Maeda H., Saitou R., et al. Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer-a multi-center study. Lung Cancer 49 (2005) 63-70
29. Hotta K., Kiura K., Takigawa N., Fujiwara Y., Tabata M., Ueoka H., et al. Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer. Lung Cancer 62 (2008) 236-241
30. Tammemagi C.M., Neslund-Dudas C., Simoff M., and Kvale P. Smoking and lung cancer survival: the role of co-morbidity and treatment. Chest 125 (2004) 27-37
31. Kearney D.J., Lee T.H., Reilly J.J., DeCamp M.M., and Sugarbaker D.J. Assessment of operative risk in patients undergoing lung resection: importance of predicted pulmonary function. Chest 105 (1994) 753-759
32. Mao L., Lee J.S., Kurie J.M., Fan Y.H., Lippman S.M., Lee J.J., et al. Clonal genetic alterations in the lung of current and former smokers. J Natl Cancer Inst 89 (1997) 857-862
33. Daniele R.P., Dauber J.H., Altose M.D., Rowlands Jr. D.T., and Gorenberg D.J. Lymphocytes studies in asymptomatic cigarette smokers. Am Rev Respir Dis 116 (1977) 997-1005
34. Chalmer J., Holt P.G., and Keast D. Cell-mediated immune responses to transplanted tumors in mice chronically exposed to cigarette smoke. J Natl Cancer Inst 55 (1975) 1129-1134
35. Raz D.J., He B., Rosell R., and Jablons D.M. Current concepts in bronchiolo-alveolar carcinoma biology. Clin Cancer Res 12 (2006) 3698-3704
36. Zell J.A., Ou I., Ziogas A., and Anton-Culver H. Epidemiology of bronchiolo-alveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 23 (2005) 8396-8405
37. Miller V.A., Kris M.G., Shah N., Patel J., Azzoli C., Gomez J., et al. Bronchiolo-alveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 22 (2004) 1103-1109
38. Zell J.A., Ou S.H.I., Ziogas A., and Anton-Culver H. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intra-pulmonary metastasis at diagnosis. Ann Oncol 17 (2006) 1255-1262
39. Gritz E.R., Dresler C., and Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 14 (2005) 2287-2293
40. Brundage M.D., Davies D., and Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122 (2002) 1037-1057